Jeito Capital Co-Leads €78 Million Financing in Augustine Therapeutics

By Karen Roman Private equity company Jeito Capital said it is co-leading an oversubscribed €77.7 million (USD 84.8 million) Series A financing round in Augustine Therapeutics. The founding will support Phase 2 of AGT-100216, Augustine’s main candidate for Charcot-Marie-Tooth disease...